Clinical use of rapamycin and other mTOR inhibitors as a cancer and immunotherapy treatment is becoming popular, and there is mounting evidence of the mTOR pathway's importance in neurologic and psychiatric disease. The gene discussed is MTOR; the disease is psychiatric disorder.